Chris Freeman Guardant Health, Inc. (GH) insider trading activity

Chris Freeman is Chief Commercial Officer of Guardant Health, Inc.. Currently has a direct ownership of 48,821 shares of GH, which is worth approximately $2.49 Million. The most recent transaction as insider was on Jan 01, 2024, when has been sold 1,928 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.8K

15.44% 3M change

89.46% 12M change

Total Value Held $2.49 Million

Chris Freeman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,928 Added 11.25%	15,207 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$63,073 $29.64 p/Share	2,128 Reduced 13.81%	13,279 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	7,713 Added 33.36%	15,407 Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$50,959 $37.86 p/Share	1,346 Reduced 14.89%	7,694 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	-	4,879 Added 35.05%	9,040 Common Stock
Jun 15 2022	SELL Payment of exercise price or tax liability	$64,853 $38.42 p/Share	1,688 Reduced 34.6%	3,191 Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	-	4,879 Added 50.0%	4,879 Common Stock

Chris Freeman

Chief Commercial Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account